𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer

✍ Scribed by Paul J. Mintz; Nagy A. Habib; Louise J. Jones; Georgios Giamas; Jacqueline S. Lewis; Rebecca L. Bowen; R. Charles Coombes; Justin Stebbing


Book ID
102106732
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
248 KB
Volume
113
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Estrogen regulated expression of the p21
✍ Soma Mandal; James R. Davie πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 183 KB

## Abstract The cyclin‐dependent kinase inhibitor protein p21^Waf1/Cip1^ is a potent tumor suppressor. Here, we demonstrate that estradiol regulates the p21^Waf1/Cip1^ gene. Estradiol induces p21^Waf1/Cip1^ mRNA expression within 30–60 min independent of new protein synthesis in the estrogen recept

Expression of insulin-like growth factor
✍ Jose A. Figueroa; James G. Jackson; William L. McGuire; Robert F. Krywicki; Doug πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 875 KB

The insulin-like growth factors (IGFs) have been implicated in the growth regulation of human breast cancer. Since the lCFs are associated with specific binding proteins (ICFBPs) which may modulate receptor/ligand interactions, production of IGFBPs by breast cancer cells could alter their IGF-depend

Resistance to tamoxifen-induced apoptosi
✍ Yih-Lin Chung; Meei-Ling Sheu; Shun-Chun Yang; Chi-Hung Lin; Sang-Hue Yen πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 498 KB

## Abstract Overexpression of Her2/neu is implicated in the development of resistance to the antiestrogen tamoxifen (TAM) that exerts its inhibitory effect through interaction with estrogen receptor (ER). Whereas Her2/neu and ER are believed to be important cell survival/death factors in human brea

Bidirectional interactions between the e
✍ Thomas W. Grunt; Miguel Saceda; Mary Beth Martin; Ruth Lupu; Evelyn Dittrich; Ge πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 993 KB

The responsiveness of estrogen receptor (ER)-positive breast cancer to endocrine therapy is frequently reduced in cells over-expressing c-erbB-2. Stimulation of ER suppresses c-erbB-2, indicating that estrogen controls the activity of c-erbB-2. Heregulin (HRG) has been described to bind to c-erbB-3/